AbbVie Biotechnology Ltd - 31 Mar 2025 SCHEDULE 13G/A Report for Carisma Therapeutics Inc. Common Stock, $0.001 par value (CARM)

Filing Manager: AbbVie Biotechnology Ltd
Reporting Manager: AbbVie Biotechnology Ltd.
Security: Carisma Therapeutics Inc. Common Stock, $0.001 par value
Symbol: CARM
Shares outstanding: 42,178,886 shares
Disclosed Ownership: 1,855,871 shares
Ownership: 4.4%
Form type: SCHEDULE 13G/A
Filing time: 25 Apr 2025, 16:15:16 UTC
Date of event: 31 Mar 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
AbbVie Biotechnology Ltd.	4.4%	1,855,871	0	1,855,871	/s/ Arthur C. Price	Arthur C. Price/Director